Overseas Projects Roadshow

Agendas
09:00 - 12:00
  • 主持人 Moderator
  • 李佳璇, 芬兰国家商务促进局医疗行业中国区负责人
  • Sanorita LI, Head of Heath Industry China, Business Finland
09:00 - 09:20
  • 主题报告
  • Keynote Speech
  • 瑞士：欧洲生命科学热土
  • Switzerland: The Life Sciences Hotspot in Europe
  • 施万德, 瑞士驻华大使馆贸易与投资处首席投资官兼副主任
  • Kuno Gschwend, Deputy Head and Chief Investment Promotion Officer of the Swiss Business Hub China, Embassy of Switzerland in China
09:20 - 09:40
  • 项目1
  • Project 1
  • 先发制癌：RNA表观转录组血检将癌症扼杀于摇篮
  • First-Strike Screening with Epitranscriptomics & AI: Stop Colorectal Cancer Before It Exists
  • 张理升, 荃慕生物科技首席执行官
  • ZHANG Li Sheng, CEO,QuantModE Co., Ltd.
09:40 - 10:00
  • 项目2
  • Project 2
  • 基于AI边缘算法和靶向神经调节技术的降血压穿戴设备
  • Based on Edge Al and Targeted Neural Modulation Techniques
  • 纪华雷, 加拿大越凡医疗有限公司董事长
  • Ray JI, CEO, WAT Medical Enterprise Ltd
10:00 - 10:20
  • 项目3
  • Project 3
  • Radiance Biopharma, A Clinical Stage Biotechnology Company Developing Next Generation Antibody Drug Conjugates to Treat Cancer and Other Unmet Needs
  • Radiance Biopharma, A Clinical Stage Biotechnology Company Developing Next Generation Antibody Drug Conjugates to Treat Cancer and Other Unmet Needs
  • Robert K. Brook, Radiance Biopharma首席执行官
  • Robert K. Brook, CEO,Radiance Biopharma
10:20 - 10:40
  • 项目4
  • Project 4
  • TPD² Approach - Dual-precision Targeted Protein Degradation
  • TPD² Approach - Dual-precision Targeted Protein Degradation
  • Sungjoo LEE, Orum Therapeutics首席执行官
  • Sungjoo LEE, CEO, Orum Therapeutics
10:40 - 11:00
  • 项目5
  • Project 5
  • CytoSpark®微流控高通量筛选系统
  • CytoSpark® Microfluidic High-throughput Screening System
  • 万玮, Hong Kong DPBio Technology Limited副总裁
  • WAN Wei, VP,Hong Kong DPBio Technology Limited
11:00 - 11:20
  • 项目6
  • Project 6
  • 奥克兰岛猪——异种移植及再生医学新平台
  • Leading A New Era in Xenotransplantation and Regenerative Medicine
  • 黄文静, 新诺生物（香港）有限公司首席执行官
  • HUANG Wenjing, CEO,NZeno Biontech (HK) Limited.
11:20 - 11:40
  • 项目7
  • Project 7
  • 计算策略驱动的药物设计方案
  • Computational Strategy-driven Drug Design
  • 刘天悦, 深度感知生物信息有限公司首席执行官
  • LIU Tianyue, CEO, DeepSense Bio Information Co., Ltd.
11:40 - 12:00
  • 项目8
  • Project 8
  • 基于神经体生物标志物与人工智能的便携式体外诊断设备，用于帕金森病早期筛查的验证报告
  • Validation of A Portable IVD device for Early Parkinson’s Disease Screening Using Neurosomal Biomarkers and Artificial Intelligence [NEUROSOMIX]
  • Robert Jenkins Hamley, Biosomic Technologies, Inc首席执行官
  • Robert Jenkins Hamley, CEO of Biosomic Technologies, Inc